Accessibility Menu

Bristol-Myers Squibb(FRA) BRM

Market Cap€117.80BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1998)+246%
5 Year+3%
1 Year+42%
1 Month+2%
€57.38
+0.83%
+0.47Today
Bristol-Myers Squibb last closing stock price
MetricPriceDate
Last closeEUR 57.402026-09-01
Bristol-Myers Squibb stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.07%EUR 58.022026-08-25
1 month+2.21%EUR 56.162026-07-31
3 month+21.79%EUR 47.132026-06-03
Year to date+24.78%EUR 46.002025-12-30
1 year+42.04%EUR 40.412025-09-01
3 year-0.17%EUR 57.502023-09-01
5 year+3.37%EUR 55.532021-09-02
Since inception+245.78%EUR 16.461998-02-27

Bristol-Myers Squibb Financials at a Glance

Market Cap

€117.80BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€42.19K

Net Income (TTM)

€7.95K

EPS (TTM)

€3.89

P/E Ratio

14.82

Dividend

€2.16

Beta (Volatility)

0.01 (Low)

Price

€57.38

Volume

0

Open

€57.38

Previous Close

€56.91

Daily Range

€57.38 - €57.38

52-Week Range

€36.65 - €60.64

Estimated Earnings Date

N/A

BRM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bristol-Myers Squibb

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.

Industry

Pharmaceuticals

Sector

Health Care

Employees

32,500

CEO

Christopher S. Boerner, PhD, MBA

Website

www.bms.com

BRM Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

46.30%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

6.75%

Dividend Yield

3.75%

Payout Ratio

N/A

Stock Overview

Market Cap

€117.80BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.04B

Volume

0

Avg. Volume

433.864

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Bristol-Myers Squibb Performance Analysis

Bristol-Myers Squibb annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 43,920,197,92511.9%
20232023-12-31EUR 41,629,220,664-5.2%
20242024-12-31EUR 44,652,318,3437.3%
20252025-12-31EUR 42,703,297,521-4.4%
Bristol-Myers Squibb annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 2.816.4%
20232023-12-31EUR 3.5727.3%
20242024-12-31EUR -4.08N/A
20252025-12-31EUR 3.07N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€11.17K

+1.1%

Gross Profit

€7.59K

+1.0%

Gross Margin

67.95%

+0.9%

Market Cap

€117.80BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€3.19

N/A

Employees

32,500

N/A

Net Income

€2.85K

+1.5%

EBITDA

€4.55K

+1.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€47.03K

-16.8%

Total Debt

€39.41K

+0.9%

Accounts Receivable

€8.03K

+0.9%

Inventory

€2.39K

+1.0%

Long Term Debt

€38.33K

+1.0%

Short Term Debt

€1.08K

+0.3%

Return on Assets

10.12%

+1.8%

Return on Invested Capital

5.80%

+4.7%

Free Cash Flow

€2.66K

+0.9%

Operating Cash Flow

€2.92K

+0.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
WETOWetour Robotics
$5.48-0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$71.92+0.00%
IBITiShares Bitcoin Trust
$44.67+0.02%
INTCIntel
$89.51+0.00%

Questions About BRM

What is the current price of Bristol-Myers Squibb?

Bristol-Myers Squibb is trading at €57.38 per share.

What is the 52-week range for Bristol-Myers Squibb?

Over the past 52 weeks, Bristol-Myers Squibb has traded between €36.65 and €60.64.

How much debt does Bristol-Myers Squibb have?

As of the most recent reporting period, Bristol-Myers Squibb reported total debt of €39.41B.

How much cash does Bristol-Myers Squibb have on hand?

Bristol-Myers Squibb reported €7.63B in cash and cash equivalents in its most recent financial results.

What is Bristol-Myers Squibb’s dividend yield?

Bristol-Myers Squibb currently has a dividend yield of 3.75%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services